Prediction Model of the Blood Pressure Response to the Administration of Fluids in Abdominal Surgery Using the Pram Method.
PREDICTPRAM
1 other identifier
observational
320
0 countries
N/A
Brief Summary
Fluid therapy is considered a first-line therapy in resuscitation protocols for hemodynamically unstable patients. The administration of fluids usually translates into an increase in Cardiac Output. However, not all patients increase mean blood pressure after fluid administration. To determine if fluids the administration improves blood pressure, it is necessary to evaluate the dependence of preload, vasomotor tone, and left ventricular stroke volume. The aim of this study is to confirm the usefulness of dynamic elastance, cardiovascular impedance, cardiac cycle efficiency, and other hemodynamic parameters calculated with the PRAM method as predictors of blood pressure response after fluid administration in open abdominal surgery. This will allow us to make and evaluate a predictive model for the blood pressure response after fluid administration in open abdominal surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2020
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 5, 2020
CompletedFirst Posted
Study publicly available on registry
October 20, 2020
CompletedStudy Start
First participant enrolled
November 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2023
CompletedOctober 22, 2020
October 1, 2020
Same day
October 5, 2020
October 20, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Dynamic elastacy ratio PPV/SVV
PPV/SVV
During surgery
Study Arms (2)
Responders
Non responders
Interventions
Patients will be treated in accordance with the criteria of the responsible physician and the hemodynamic data obtained with the Mostcareup monitor will be recorded and used for decision-making according to the hemodynamic management protocols of each center. If the patient has a PPV ≥ 14%, for 3 minutes and a MAP \<65 mm Hg or a Systolic Blood Pressure \<90 mm Hg, a bolus volume load of 3 ml / kg weight of a balanced crystalloid solution in a time of 10 minutes36,37. The start of the volume charge (T1) will be noted by an event mark on the MostCareup monitor. The end of the volume charge (T2) will be noted by an event mark on the MostCareup monitor. Five minutes after the completion of the volume charge a new event will be marked on the MostCare monitor (T3). Both brands will serve as a reference for the analysis of hemodynamic data. Patients will be considered responders to the administration of fluids if the cardiac index (CI) increase.
Eligibility Criteria
Patients scheduled for open abdominal surgery, older than 18 years. All sex participates and not gender based.
You may qualify if:
- Patients ≥ 18 years
- Patients scheduled for open abdominal surgery lasting ≥ 120 minutes under general anesthesia with mechanical ventilation and the use of VT of 8 ml / kg ideal weight and who require serious arterial monitoring.
You may not qualify if:
- Patients \<18 years.
- Patients\> 80 years.
- Pregnant women.
- Urgent surgery.
- ASA \>3
- Pathologies that may alter the quality of the arterial signal due to alterations of the dicrotic incisura.
- Poor quality of the arterial pressure wave due to artifacts of the transduction system (resonance and damping).
- Personal history of:
- Cardiac arrhythmia.
- Left ventricular ejection fraction \<30%
- Right ventricular dysfunction (peak systolic tricuspid annulus velocity \<0.16 m / sec)
- Intracardiac shunt
- Preoperative creatinine\> 1.4 mg / dl.
- Dialysis
- Previous treatment with beta-blockers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Anesthetist
Study Record Dates
First Submitted
October 5, 2020
First Posted
October 20, 2020
Study Start
November 1, 2020
Primary Completion
November 1, 2020
Study Completion
November 1, 2023
Last Updated
October 22, 2020
Record last verified: 2020-10